These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8328767)

  • 1. [Flare-up study and gonadotropin extinction curve in patients treated with long-acting triptorelin, 3.75 mg im].
    Vizziello G; D'Amato G; Trentadue R; Fanizza G
    Ann Ostet Ginecol Med Perinat; 1993; 113(3):143-7. PubMed ID: 8328767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
    Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
    N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the steroid sex hormones on the LH and FSH responses to LHRH in the normal subject].
    Lemarchand-Béraud T; Reymond M; Rappoport G; Magrini G; Gomez J
    Pathol Biol (Paris); 1975 Dec; 23(10):917-22. PubMed ID: 772543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men.
    Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D
    J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR.
    Broekmans FJ; Bernardus RE; Berkhout G; Schoemaker J
    Gynecol Endocrinol; 1992 Sep; 6(3):153-61. PubMed ID: 1442160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
    Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
    Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical ovarian stimulations in the use of LHRH analogs.
    Parinaud J; Oustry P; Bussenot I; Tourre A; Perineau M; Plantavid M; Monrozies X; Reme JM; Pontonnier G
    Eur J Obstet Gynecol Reprod Biol; 1992 Nov; 47(2):129-33. PubMed ID: 1459326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term treatment of male and female precocious puberty by periodic administration of a long-acting preparation of D-Trp6-luteinizing hormone-releasing hormone microcapsules.
    Roger M; Chaussain JL; Berlier P; Bost M; Canlorbe P; Colle M; Francois R; Garandeau P; Lahlou N; Morel Y
    J Clin Endocrinol Metab; 1986 Apr; 62(4):670-7. PubMed ID: 2936759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT; Ohlinger R
    Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone administration inhibits gonadotropin secretion by an effect directly on the human pituitary.
    Sheckter CB; Matsumoto AM; Bremner WJ
    J Clin Endocrinol Metab; 1989 Feb; 68(2):397-401. PubMed ID: 2493030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Short-term comparison of the treatment of precocious puberty with 2 different LHRH antagonists (buserelin and long-acting triptorelin). An endocrinologic and echographic study].
    Cicognani A; Cacciari E; Balsamo A; Cassio A; Papasodero A; Bellizzi M; Guacci P; Zappulla F
    Pediatr Med Chir; 1994; 16(1):43-8. PubMed ID: 8029088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of gonadotropin-releasing hormone and its agonists on prolactin secretion from normal and tumorous pituitary cells.
    Lamberts SW; Uitterlinden P; Reubi JC; de Jong FH
    Neuroendocrinology; 1989 Feb; 49(2):157-63. PubMed ID: 2524674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of pharmacological hypogonadotropism using gonadotropin-releasing hormone agonists in patients undergoing controlled ovarian stimulation.
    Lindner C; Braendle W; Lichtenberg V; Bettendorf G
    Gynecol Obstet Invest; 1990; 29(2):132-9. PubMed ID: 2139863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of the ratio of bioactive to immunoreactive follicle-stimulating hormone in normal men during chronic luteinizing hormone-releasing hormone agonist administration.
    Pavlou SN; Dahl KD; Wakefield G; Rivier J; Vale W; Hsueh AJ; Lindner J
    J Clin Endocrinol Metab; 1988 May; 66(5):1005-9. PubMed ID: 2834409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of gonadotropin-releasing hormone (GnRH) receptor gene is altered by GnRH agonist desensitization in a manner similar to that of gonadotropin beta-subunit genes in normal and castrated rat pituitary.
    Lerrant Y; Kottler ML; Bergametti F; Moumni M; Blumberg-Tick J; Counis R
    Endocrinology; 1995 Jul; 136(7):2803-8. PubMed ID: 7789305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART.
    Sonntag B; Kiesel L; Nieschlag E; Behre HM
    J Assist Reprod Genet; 2005 Aug; 22(7-8):277-83. PubMed ID: 16195824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of different puberty inhibiting mechanisms of two GnRH agonists and the GnRH antagonist cetrorelix using a female rat model.
    Roth C; Leonhardt S; Seidel C; Luft H; Wuttke W; Jarry H
    Pediatr Res; 2000 Oct; 48(4):468-74. PubMed ID: 11004237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen inhibits luteinizing hormone (LH), but not follicle-stimulating hormone secretion in hypophysectomized pituitary-grafted rats receiving pulsatile LH-releasing hormone infusions.
    Strobl FJ; Levine JE
    Endocrinology; 1988 Jul; 123(1):622-30. PubMed ID: 3133202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.